Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.

M. Santucci; N Pimpinelli; D Massi; ME Kadin; C.J.L.M. Meijer; HK Muller-Hermelink; M Paulli; J. Wechsler; R. Willemze; H Audring; MG Bernengo; L. Cerroni

doi:10.1002/cncr.11107

Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.

M. Santucci
, N Pimpinelli
, D Massi
, ME Kadin
, C.J.L.M. Meijer
, HK Muller-Hermelink
, M Paulli
, J. Wechsler
, R. Willemze
, H Audring
, MG Bernengo
, L. Cerroni

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	610-27
Journal	Cancer
Volume	97
Issue number	3
DOIs	https://doi.org/10.1002/cncr.11107
Publication status	Published - 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1002/cncr.11107

Cite this

@article{4f30e307821c406cbfcf5ed1b660a51c,

title = "Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.",

author = "M. Santucci and N Pimpinelli and D Massi and ME Kadin and C.J.L.M. Meijer and HK Muller-Hermelink and M Paulli and J. Wechsler and R. Willemze and H Audring and MG Bernengo and L. Cerroni",

year = "2003",

doi = "10.1002/cncr.11107",

language = "English",

volume = "97",

pages = "610--27",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

TY - JOUR

T1 - Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.

AU - Santucci, M.

AU - Pimpinelli, N

AU - Massi, D

AU - Kadin, ME

AU - Meijer, C.J.L.M.

AU - Muller-Hermelink, HK

AU - Paulli, M

AU - Wechsler, J.

AU - Willemze, R.

AU - Audring, H

AU - Bernengo, MG

AU - Cerroni, L.

PY - 2003

Y1 - 2003

U2 - 10.1002/cncr.11107

DO - 10.1002/cncr.11107

M3 - Article

SN - 0008-543X

VL - 97

SP - 610

EP - 627

JO - Cancer

JF - Cancer

IS - 3

ER -